Details for 2019161388
Up to date per 22.04.2026
Actions
Details for 2019161388
Granted/Registered
European Patent
11.09.2019 A
25.10.2023 B1
29.04.2014
US
201461985589 P
16.05.2014
US
201461994310 P
C12N 5/00 20060101AFI20190522BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LAUX, HolgerNovartis Pharma AG Postfach 4002 BaselCH
ROMAND, SandrineNovartis Pharma AG Postfach 4002 BaselCH
BODENDORF, UrsulaNovartis Pharma AG Postfach 4002 BaselCH
Information about Fees